Katherine Ansley to Breast Neoplasms
This is a "connection" page, showing publications Katherine Ansley has written about Breast Neoplasms.
Connection Strength
0.618
-
Thomas A, O'Connell NS, Douglas E, Hatcher S, Park CJ, Dent S, Ansley K, Klem I, Bansal R, Westbrook K, Hundley WG, Bottinor W, Hackney MH, Richardson KM, Sirkisoon SR, D'Agostino RB, Jordan JH. Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study. Am Heart J. 2024 Jan; 267:33-43.
Score: 0.143
-
Bowers HJ, Douglas E, Ansley K, Thomas A, Weis JA. Dynamic characterization of breast cancer response to neoadjuvant therapy using biophysical metrics of spatial proliferation. Sci Rep. 2022 Jul 09; 12(1):11718.
Score: 0.131
-
Jordan JH, D'Agostino RB, Ansley K, Douglas E, Melin S, Sorscher S, Vasu S, Park S, Kotak A, Romitti PA, O'Connell NS, Hundley WG, Thomas A. Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor. JNCI Cancer Spectr. 2021 Aug; 5(4).
Score: 0.122
-
Lycan TW, Hsu FC, Ahn CS, Thomas A, Walker FO, Sangueza OP, Shiozawa Y, Park SH, Peters CM, Romero-Sandoval EA, Melin SA, Sorscher S, Ansley K, Lesser GJ, Cartwright MS, Strowd RE. Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer. Muscle Nerve. 2020 05; 61(5):587-594.
Score: 0.111
-
Sorscher S, Ansley K, Delaney SD, Ramkissoon S. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1). Breast Cancer Res Treat. 2020 Apr; 180(2):511-514.
Score: 0.111